Cargando…
The Impact of an Efflux Pump Inhibitor on the Activity of Free and Liposomal Antibiotics against Pseudomonas aeruginosa
The eradication of Pseudomonas aeruginosa in cystic fibrosis patients has become continuously difficult due to its increased resistance to treatments. This study assessed the efficacy of free and liposomal gentamicin and erythromycin, combined with Phenylalanine arginine beta-naphthylamide (PABN), a...
Autores principales: | Gbian, Douweh Leyla, Omri, Abdelwahab |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8072581/ https://www.ncbi.nlm.nih.gov/pubmed/33919624 http://dx.doi.org/10.3390/pharmaceutics13040577 |
Ejemplares similares
-
Lipid-Based Drug Delivery Systems for Diseases Managements
por: Gbian, Douweh Leyla, et al.
Publicado: (2022) -
Efflux pump inhibitors (EPIs) as new antimicrobial agents against Pseudomonas aeruginosa
por: Askoura, Momen, et al.
Publicado: (2011) -
Evaluation of Heterocyclic Carboxamides as Potential Efflux Pump Inhibitors in Pseudomonas aeruginosa
por: Yuan, Yi, et al.
Publicado: (2021) -
Spread of Efflux Pump Overexpressing-Mediated Fluoroquinolone Resistance and Multidrug Resistance in Pseudomonas aeruginosa by using an Efflux Pump Inhibitor
por: Adabi, Maryam, et al.
Publicado: (2015) -
Role of Efflux Pumps on Antimicrobial Resistance in Pseudomonas aeruginosa
por: Lorusso, Andre Bittencourt, et al.
Publicado: (2022)